Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Double-blind crossover versus parallel groups in hypertension.

P S Sever1, N R Poulter, C S Bulpitt

  • 1Department of Clinical Pharmacology, St Mary's Hospital, London, England.

American Heart Journal
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue Doppler echocardiography predicts long-term cardiovascular mortality: the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy 20-year follow-up study.

Open heart·2025
Same author

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis.

Canadian journal of diabetes·2015
Same author

The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2013
Same author

ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data.

Journal of human hypertension·2013
Same author

Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus.

Diabetologia·2012
Same author

Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Clinical trial design is crucial for evaluating antihypertensive drugs. Parallel group designs are often preferred over crossover designs to minimize bias and dropout rates for accurate blood pressure assessments.

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Cardiovascular Medicine

Background:

  • Antihypertensive drug efficacy requires rigorous clinical trial evaluation.
  • Trial design must minimize variability, bias, and ensure adequate statistical power.
  • Participant and observer variability, order effects, and patient dropout are key concerns.

Purpose of the Study:

  • To compare the suitability of parallel group versus crossover designs for antihypertensive drug trials.
  • To highlight the strengths and limitations of each design in evaluating drug efficacy.
  • To inform optimal clinical trial methodologies for blood pressure management.

Main Methods:

  • Discussion of parallel group design advantages: avoids order/carryover effects, suitable for long-term response assessment.

Related Experiment Videos

  • Discussion of crossover design advantages: requires fewer subjects, more economical.
  • Emphasis on necessary corrections for order and carryover effects in crossover trials.

    • Main Results:

    • Parallel group designs are generally preferred for comparing multiple active drugs or drugs versus placebo.
    • Crossover designs can be economical but primarily assess short-term blood pressure responses.
    • Extrapolation of short-term crossover data to long-term clinical practice requires caution.

    Conclusions:

    • Parallel group designs offer robust evaluation of antihypertensive efficacy, especially for longer durations.
    • Crossover designs are viable for short-term assessments but necessitate careful design to mitigate bias.
    • Careful consideration of trial design is essential for accurate antihypertensive drug evaluation and clinical application.